Enlivex Therapeutics Ltd. (NASDAQ:ENLV – Get Free Report) saw a significant decrease in short interest in the month of February. As of February 15th, there was short interest totalling 105,100 shares, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback